Are changes necessary in the medical management of a patient with snakebite regarding the incidence of hypersensitivity reaction to antivenom polyvalent immune fab?

Clin Toxicol (Phila). 2018 Apr;56(4):310-311. doi: 10.1080/15563650.2017.1367400. Epub 2017 Aug 23.

Authors

Claire Mailhol¹, Nicolas Delcourt², Pôl-André Apoil³, Alain Didier¹, Nicolas Franchitto²

Affiliations

¹ a Pneumology and Allergology Department , Toulouse-Larrey University Hospital , Toulouse , France.
² b Poison Control Center , Toulouse-Purpan University Hospital , Toulouse , France.
³ c Immunology Department , Toulouse-Rangueil University Hospital , Toulouse , France.

PMID: 28830265
DOI: 10.1080/15563650.2017.1367400

No abstract available

Publication types

Letter
Comment

MeSH terms

Antivenins
Galactose
Humans
Hypersensitivity*
Immunoglobulin Fab Fragments
Incidence
Snake Bites*

Substances

Antivenins
Crotalidae Polyvalent immune Fab
Immunoglobulin Fab Fragments
Galactose